BRIEF published on 12/05/2024 at 15:15, 11 months 30 days ago CNS Pharmaceuticals Announces Virtual Analyst & Investor Day CNS Pharmaceuticals Virtual Analyst Day Glioblastoma Multiforme Berubicin TPI 287
BRIEF published on 12/05/2024 at 15:15, 11 months 30 days ago CNS Pharmaceuticals annonce une journée virtuelle pour les analystes et les investisseurs TPI 287 Produits Pharmaceutiques Pour Le Système Nerveux Central Journée Virtuelle Des Analystes Glioblastome Multiforme Bérubicine
PRESS RELEASE published on 12/05/2024 at 15:10, 11 months 30 days ago CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024 CNS Pharmaceuticals, Inc. announces a live webcast discussion with GBM Key Opinion Leaders on Dec 11th. Experts to talk about Berubicin and TPI 287 development Webcast CNS Pharmaceuticals Berubicin TPI 287 GBM
Published on 12/05/2025 at 02:35, 4 hours 6 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 41 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 36 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 41 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 11 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 50 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 16 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 26 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 30 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 26 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 41 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 41 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 56 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 56 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
